243 related articles for article (PubMed ID: 32387660)
1. COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.
Carugno A; Gambini DM; Raponi F; Vezzoli P; Locatelli AGC; Di Mercurio M; Robustelli Test E; Sena P
J Am Acad Dermatol; 2020 Jul; 83(1):292-294. PubMed ID: 32387660
[No Abstract] [Full Text] [Related]
2. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
Gisondi P; Facheris P; Dapavo P; Piaserico S; Conti A; Naldi L; Cazzaniga S; Malagoli P; Costanzo A
Br J Dermatol; 2020 Aug; 183(2):373-374. PubMed ID: 32343839
[No Abstract] [Full Text] [Related]
3. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Wan MT; Shin DB; Winthrop KL; Gelfand JM
J Am Acad Dermatol; 2020 Aug; 83(2):677-679. PubMed ID: 32416207
[No Abstract] [Full Text] [Related]
4. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?
Megna M; Fabbrocini G; Marasca C
Int J Dermatol; 2020 Sep; 59(9):1144-1145. PubMed ID: 32710548
[No Abstract] [Full Text] [Related]
5. Remote management of hidradenitis suppurativa in a pandemic era of COVID-19.
Kang NC; Hsiao J; Shi V; Naik HB; Lowes MA; Alavi A
Int J Dermatol; 2020 Sep; 59(9):e318-e320. PubMed ID: 32578210
[No Abstract] [Full Text] [Related]
6. Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic.
Geskin LJ; Trager MH; Aasi SZ; Bickers DR; Carvajal RD; Nghiem P; Taback B; Zeitouni NC; Samie FH
J Am Acad Dermatol; 2020 Jul; 83(1):295-296. PubMed ID: 32387656
[No Abstract] [Full Text] [Related]
7. Which are the "emergent" dermatologic practices during COVID-19 pandemic? Report from the lockdown in Milan, Italy.
Giacalone S; Bortoluzzi P; Nazzaro G
Int J Dermatol; 2020 Aug; 59(8):e269-e270. PubMed ID: 32501536
[No Abstract] [Full Text] [Related]
8. Patients with bullous skin disease in a high-epidemic COVID-19 area, Bergamo, Italy.
Carugno A; Sena P; Raponi F; Robustelli Test E; Vezzoli P
Br J Dermatol; 2020 Sep; 183(3):589-591. PubMed ID: 32479659
[No Abstract] [Full Text] [Related]
9. Asynchronous teledermatology in medical education: Lessons from the COVID-19 pandemic.
Su MY; Lilly E; Yu J; Das S
J Am Acad Dermatol; 2020 Sep; 83(3):e267-e268. PubMed ID: 32553635
[No Abstract] [Full Text] [Related]
10. Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
Georgakopoulos JR; Mufti A; Vender R; Yeung J
J Am Acad Dermatol; 2020 Oct; 83(4):1212-1214. PubMed ID: 32679279
[No Abstract] [Full Text] [Related]
11. The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Syed MN; Shin DB; Wan MT; Winthrop KL; Gelfand JM
J Am Acad Dermatol; 2020 Nov; 83(5):1523-1526. PubMed ID: 32622891
[No Abstract] [Full Text] [Related]
12. Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic.
Sanchez DP; Kirsner RS; Lev-Tov H
J Am Acad Dermatol; 2020 Jul; 83(1):288-292. PubMed ID: 32380214
[No Abstract] [Full Text] [Related]
13. Applying to dermatology residency during the COVID-19 pandemic.
Kearns DG; Chat VS; Uppal S; Wu JJ
J Am Acad Dermatol; 2020 Oct; 83(4):1214-1215. PubMed ID: 32652192
[No Abstract] [Full Text] [Related]
14. Modifications to dermatology residency education during the COVID-19 pandemic.
Mufti A; Maliyar K; Sachdeva M; Doiron P
J Am Acad Dermatol; 2020 Sep; 83(3):e235-e236. PubMed ID: 32497696
[No Abstract] [Full Text] [Related]
15. Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic.
Trinidad J; Kroshinsky D; Kaffenberger BH; Rojek NW
J Am Acad Dermatol; 2020 Jul; 83(1):e69-e71. PubMed ID: 32339708
[No Abstract] [Full Text] [Related]
16. Hematopoietic stem cell transplantation dilemma during the COVID-19 era.
Samaha R; Kattan J
Future Oncol; 2020 Aug; 16(22):1569-1573. PubMed ID: 32458703
[No Abstract] [Full Text] [Related]
17. Pattern of vascular disease in Lombardy, Italy, during the first month of the COVID-19 outbreak.
Melissano G; Mascia D; Baccellieri D; Kahlberg A; Bertoglio L; Rinaldi E; Chiesa R
J Vasc Surg; 2020 Jul; 72(1):4-5. PubMed ID: 32360680
[No Abstract] [Full Text] [Related]
18. Managing the COVID-19 pandemic: international comparisons in dialysis patients.
Kliger AS; Cozzolino M; Jha V; Harbert G; Ikizler TA
Kidney Int; 2020 Jul; 98(1):12-16. PubMed ID: 32471637
[No Abstract] [Full Text] [Related]
19. Medical student dermatology rotations in the context of COVID-19.
Muzumdar S; Grant-Kels JM; Feng H
J Am Acad Dermatol; 2020 Nov; 83(5):1557-1558. PubMed ID: 32592884
[No Abstract] [Full Text] [Related]
20. The ethics of charging patients an infection control fee in the context of COVID-19.
Muzumdar S; Grant-Kels JM; Feng H
J Am Acad Dermatol; 2020 Sep; 83(3):981-982. PubMed ID: 32561374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
